• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2009 Fiscal Year Final Research Report

The investigation into the efficacy of angiotensin receptor blocker against metabolic syndrome

Research Project

  • PDF
Project/Area Number 20790401
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Applied pharmacology
Research InstitutionKyoto Pharmaceutical University

Principal Investigator

TOBA Hiroe  Kyoto Pharmaceutical University, 薬学部, 助教 (90351270)

Project Period (FY) 2008 – 2009
Keywords臨床薬理学 / メタボリックシンドローム
Research Abstract

We have demonstrated that telmisartan inhibited renal and aortic injury in the diabetic rat model and these beneficial effects were stronger than those of other angiotensin receptor blocker (ARB), which have exhibitied similar antihypertensive effects to those of telmisartan. In addition, we also showed that treatment with telmisartan suppressed inflammation in the H_2O_2-treated cultured vascular endothelial cells by PPARγ.

  • Research Products

    (9 results)

All 2010 2009 2008

All Journal Article (5 results) (of which Peer Reviewed: 5 results) Presentation (4 results)

  • [Journal Article] Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.2010

    • Author(s)
      Kobara M, Noda K, Kitamura M, Okamoto A, Shiraishi T, Toba H, Matsubara H, Nakata T.
    • Journal Title

      Cardiovascular Research (in press)

    • Peer Reviewed
  • [Journal Article] Oral L-histidine exerts antihypertensive effects via central histamine H3 receptors and decreases nitric oxide content in the rostral ventrolateral medulla in spontaneously hypertensive rats.2010

    • Author(s)
      Toba H, Nakamori A, Tanaka Y, Yukiya R, Tatsuoka K, Narutaki M, Tokitaka M, Hariu H, Kobara M, Nakata T.
    • Journal Title

      Clininal and Experimental Pharmacology and Physiology 37(1)

      Pages: 62-68

    • Peer Reviewed
  • [Journal Article] Nakata TChronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat.2009

    • Author(s)
      Toba H, Sawai N, Morishita M, Murata S, Yoshida M, Nakashima K, Morita Y, Kobara M
    • Journal Title

      European Journal of Pharmacology 612(1-3)

      Pages: 106-114

    • Peer Reviewed
  • [Journal Article] Nakata T Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.2008

    • Author(s)
      Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M
    • Journal Title

      European Journal of Pharmacology 589(1-3)

      Pages: 264-271

    • Peer Reviewed
  • [Journal Article] Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis2008

    • Author(s)
      Hayashi H, Kobara M, Abe M, Tanaka N, Gouda E, Toba H, Yamada H, Tatsumi T, Nakata T, Matsubara H.
    • Journal Title

      Hypertension Research 31(2)

      Pages: 363-375

    • Peer Reviewed
  • [Presentation] Pitavastatin inhibited diabetic nephropathy and decreased renal renin-angiotensin-aldosterone system in rats.2009

    • Author(s)
      Hiroe Toba, Nobuyoshi Imai, Ryoko Serizawa, Tamotsu Takahashi, Takuya Mitani, Miyuki Kobara, Tetsuo Nakata.
    • Organizer
      19th European Meeting on Hypertension
    • Place of Presentation
      Milan, Italy
    • Year and Date
      2009-06-13
  • [Presentation] Chronic treatment with Erythropoietin inhibits oxidative stress and inflammatory reaction in diabetic rat aorta beyond hematopoiesis.2009

    • Author(s)
      Hiroe Toba, Mamiko Yoshida, Kohei Nakashima, Masayuki Morishita, Shoko Murata, Chisato Tojo, Yuko Oshima, Yosuke Morita, Miyuki Kobara, Tetsuo Nakata.
    • Organizer
      19th European Meeting on Hypertension
    • Place of Presentation
      Milan, Italy
    • Year and Date
      2009-06-13
  • [Presentation] Erythropoietin attenuates diabetic nephropathy beyond hematopoiesis in streptozotocin-induced diabetic rats.2008

    • Author(s)
      Hiroe Toba, Naoki Sawai, Yosuke Morita, Kohei Nakashima, Mamiko Yoshida, Masayuki Morishita, Miyuki Kobara, Tetsuo Nakata.
    • Organizer
      Hypertension2008
    • Place of Presentation
      Berlin, Germany
    • Year and Date
      2008-06-19
  • [Presentation] Spironolactone attenuated renal and vascular dysfunction via antioxidant properties and inhibited renal expression of ACE and CYP11B2 in deoxycorticosterone-salt rats.2008

    • Author(s)
      Hiroe Toba, Masafumi Murakami, Takuya Mitani, Nobuyoshi Imai, Ryoko Serizawa, Miyuki Kobara, Tetsuo Nakata.
    • Organizer
      Hypertension
    • Place of Presentation
      Berlin, Germany
    • Year and Date
      2008-06-16

URL: 

Published: 2011-06-18   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi